Hospitalizations and mortality in the Lung Health Study.
Nicholas R Anthonisen, John E Connett, Paul L Enright...
https://pubmed.ncbi.nlm.nih.gov/12153966/Completed
Phase 3
Age: 35Years - 60Years
All Genders
ID00000568
Lung Health Study (LHS) I and III
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2016-04-14
N/A
Participants Needed
N/A
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
In the Lung Health Study I, to determine the effects of Special Care, compared to Usual Care, on rate of decline in pulmonary function in a group of cigarette smokers identified as having mild abnormalities in pulmonary function. In the Lung Health Study III, to determine the long-term effects of smoking cessation and continued smoking, on cardiopulmonary morbidity, mortality, and the rate of decline in the one second forced expiratory volume (FEV1) in men and women with early chronic obstructive lung disease who have been followed prospectively for 12 to 15 years.
CONDITIONS
Brief Title
Lung Health Study (LHS) I and III
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here